A detailed history of Pnc Financial Services Group, Inc. transactions in Biote Corp. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 437 shares of BTMD stock, worth $1,101. This represents 0.0% of its overall portfolio holdings.

Number of Shares
437
Previous 612 28.59%
Holding current value
$1,101
Previous $2,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025

SELL
$2.82 - $4.55 $493 - $796
-175 Reduced 28.59%
437 $1,000
Q2 2025

Aug 08, 2025

BUY
$3.25 - $4.28 $1,989 - $2,619
612 New
612 $2,000
Q1 2024

May 10, 2024

BUY
$3.79 - $6.91 $60 - $110
16 Added 123.08%
29 $0
Q4 2023

Feb 09, 2024

BUY
$4.43 - $5.81 $57 - $75
13 New
13 $0

Others Institutions Holding BTMD

About biote Corp.


  • Ticker BTMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 7,574,270
  • Market Cap $19.1M
  • Description
  • biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...
More about BTMD
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.